ロード中...
Clozapine versus typical neuroleptic medication for schizophrenia
BACKGROUND: Long‐term drug treatment of schizophrenia with typical antipsychotic drugs has limitations: 25 to 33% of sufferers have illnesses that are treatment resistant. Clozapine is an antipsychotic drug, which is claimed to have superior efficacy and to cause fewer motor adverse effects than typ...
保存先:
| 出版年: | Cochrane Database Syst Rev |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Ltd
2009
|
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7065592/ https://ncbi.nlm.nih.gov/pubmed/19160174 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD000059.pub2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|